- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04634019
Financially-Incentives to Improve Provider Compliance
Financially-Incentivized Knowledge Assessments to Improve Provider Compliance With Treatment Guidelines: A Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The main idea of the intervention is to conduct quarterly provider knowledge assessments at health facilities and to pay facilities a bonus if providers perform well on these tests. For the intervention, 12 clinical vignettes were created. These vignettes cover typical patient cases such as malaria, diarrhea and respiratory infections, and assess providers' ability to correctly diagnose and treat hypothetical questions. All medical staff members were informed hat every 3 month there would be a knowledge assessment based on these vignettes and that the results would determine the total bonus payment made to the facility.
Each quarter, facilities receive a supervision visit. During the supervision visits, one provider is randomly chosen for the knowledge assessments, and is tested on two randomly chosen vignette cases.
In order to create a quarterly performance score, the scores on the two vignettes are then averaged. Fifty percent of the overall facility quality score is determined by the general quality checklist that captures basic structural and process features of the facility. The remaining fifty percent are directly determined by the providers' performance on the knowledge assessments. If the overall quality score is below 50%, no quality payments are made. If the quality score is >=50%, facilities can receive a top-up payment of up to 25% of the quantity-based payments. The total bonus percentage is determined by multiplying the quality score (with ranges between 0 and 100%) with the maximum 25% bonus.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Kinshasa, Congo, The Democratic Republic of the
- Congo Ministry of Public Health
-
-
-
-
BS
-
Basel, BS, Switzerland, 4051
- Swiss Tropical and Public Health Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- all providers working at the 110 facilities selected for the study will be included in the study.
Exclusion Criteria:
- none.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control arm
Providers in control facilities will not receive any additional training or knowledge assessments.
|
|
Experimental: Financial incentive arm
Providers in treatment facilities will be visited once a quarter for a knowledge assessment using vignettes.
Facilities performing well in this assessment will receive a quarterly bonus payment, which will be distributed among providers.
|
We will conduct quarterly provider knowledge assessments at selected health facilities and will pay facilities a financial bonus if providers perform well on these tests.
For the intervention, 12 clinical vignettes were created.
These vignettes cover typical patient cases such as malaria, diarrhea and respiratory infections, and assess providers' ability to correctly diagnose and treat hypothetical questions.
All medical staff members will be informed hat every 3 month there will be a knowledge assessment based on these vignettes and that the results will determine the total bonus payment made to the facility.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Compliance with integrated management of childhood illness (IMCI) guidelines
Time Frame: Endline (30 months after project start)
|
Compliance will be measured through up to 8 direct observations of under-5 sick child visits at each facility collected over a four-day period.
During each visit, trained observes will document how many of the 10 diagnostic steps specified in the WHO's Integrated Management of Child Illness (IMCI) are followed by the provider.
Compliance will be defined as least 8 out of 10 diagnostic processes completed.
|
Endline (30 months after project start)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Knowledge regarding IMCI guidelines
Time Frame: Endline (30 months after project start)
|
Knowledge of IMCI guidelines will be assessed through vignettes administered to providers at baseline and endline.
A total of five vignettes will be given to providers, each describing a scenario involving a sick child under age 5.
An overall knowledge score will be created to measure the extent to which the diagnosis and treatment chosen by providers matches those specified in the nationally used Integrated Management of Child Illness guidelines.
|
Endline (30 months after project start)
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Gil Shapira, PhD, World Bank
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- IncentLearn
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Compliant Behavior
-
University of California, BerkeleyCenters for Disease Control and Prevention, China; National Center for Rural...Active, not recruitingPollution; Exposure | Diarrheal Disease | Compliant BehaviorChina
-
University of BrasiliaUnknownLearning Process in Nursing Graduation | Compliant BehaviorBrazil
-
Monash UniversityMartin & Loreto Hosking's Three Springs Foundation; Australian Research CouncilCompletedImpulsive Behavior | Compliant Behavior | Self-ControlUnited Kingdom
-
Jakob ZeuchnerRecruitingComplication of Anesthesia | Compliant Behavior | Rapid Sequence Induction | RSISweden
-
Universitaire Ziekenhuizen KU LeuvenNot yet recruitingCompress Compliant Pre-Stress System | Malignant Bone Tumor
-
The University of Tennessee, KnoxvilleWithdrawnFeeding Behavior | Behavior | Food Habits | Behavior and Behavior MechanismsUnited States
-
Assiut UniversityNot yet recruitingAddictive Behavior | Adolescent BehaviorEgypt
-
University of FloridaNational Institute of Dental and Craniofacial Research (NIDCR)Not yet recruitingChild Behavior | Behavior and Behavior Mechanisms
-
University of California, BerkeleySave the Children; Health for a Prosperous Nation; Camara Education, Tanzania; Ubongo... and other collaboratorsCompletedBehavior, Child | Behavior, Adaptive | Behavior, SocialTanzania
-
Children's Mercy Hospital Kansas CityEnrolling by invitationEvaluating the Impact of CHOICE-AYA on Contraceptive Use, Continuation and Satisfaction (CHOICE-AYA)Sexual Behavior | Contraception Behavior | Reproductive BehaviorUnited States